BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Sees Significant Decline in Short Interest
BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) saw a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 807,700 shares, a decrease of 23.1% from the December 31st total of 1,050,000 shares. Based on an average trading volume of 801,400 shares, the short-interest ratio […]
1 Feb 13:33 · The Markets Daily